1. Home
  2. JEF vs RDY Comparison

JEF vs RDY Comparison

Compare JEF & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jefferies Financial Group Inc.

JEF

Jefferies Financial Group Inc.

N/A

Current Price

$47.22

Market Cap

10.3B

Sector

Finance

ML Signal

N/A

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$14.91

Market Cap

9.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JEF
RDY
Founded
1968
1984
Country
United States
India
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
9.9B
IPO Year
2018
2001

Fundamental Metrics

Financial Performance
Metric
JEF
RDY
Price
$47.22
$14.91
Analyst Decision
Buy
Buy
Analyst Count
6
5
Target Price
★ $55.17
$14.46
AVG Volume (30 Days)
2.2M
★ 2.8M
Earning Date
09-28-2026
10-23-2026
Dividend Yield
★ 3.38%
0.43%
EPS Growth
N/A
★ N/A
EPS
★ 0.70
N/A
Revenue
★ $10,823,677,000.00
N/A
Revenue This Year
$16.58
$4.57
Revenue Next Year
$6.55
$11.92
P/E Ratio
$67.31
★ $18.67
Revenue Growth
★ 2.93
N/A
52 Week Low
$35.53
$11.36
52 Week High
$66.60
$15.67

Technical Indicators

Market Signals
Indicator
JEF
RDY
Relative Strength Index (RSI) 49.92 77.25
Support Level $45.78 $12.92
Resistance Level $49.52 $15.67
Average True Range (ATR) 1.84 0.27
MACD 0.47 0.10
Stochastic Oscillator 40.35 98.62

Price Performance

Historical Comparison
JEF
RDY

About JEF Jefferies Financial Group Inc.

Jefferies Financial Group is a full-service investment banking and capital markets firm that was founded in 1962. After nearly 30 years of focusing on institutional trading services, it entered the investment banking industry in the early 1990s, which ultimately grew into the core business. In 2013, Jefferies merged with Leucadia, a manufacturing-focused holding company. Since the merger, Jefferies became the core of the combined business as the bulk of the legacy portfolio was sold off and the parent company was renamed to match the subsidiary. Within investment banking, Jefferies predominately serves the North American middle market and has captured considerable market share over the past decade.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: